• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Aveo Pharmaceuticals (NQ: AVEO )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Jan 19, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 14.99 (49)
    Ask (Size) 15.00 (111)
    Prev. Close 15.00
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 34,373,995
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
    From AVEO Pharmaceuticals, Inc.
    Via GlobeNewswire
    AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
    From AVEO Pharmaceuticals, Inc.
    Via GlobeNewswire

    Performance

    More News

    Read More
    AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist
    From AVEO Pharmaceuticals, Inc.
    Via GlobeNewswire
    Aveo Stock Continues Its Bullish Run After Snagging $566 Million LG Chem Buyout
    Via Investor's Business Daily
    AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
    From AVEO Pharmaceuticals, Inc.
    Via GlobeNewswire
    LG Chem Completes Acquisition of AVEO Oncology
    From AVEO Pharmaceuticals, Inc.
    Via GlobeNewswire
    AVEO Oncology Stockholders Approve Acquisition by LG Chem
    From AVEO Pharmaceuticals, Inc.
    Via GlobeNewswire
    Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
    Via MarketBeat
    Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Altra Industrial Motion Corp. (Nasdaq - AIMC), UserTesting, Inc. (NYSE - USER), AVEO Pharmaceuticals, Inc. (Nasdaq - AVEO), Limestone Bancorp, Inc. (Nasdaq - LMST)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
    Via Benzinga
    US Stock Futures Lower Following Friday's Rally; Tesla In Focus
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
    Via Benzinga
    Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday
    Via Benzinga
    Carnival, Amazon, Iamgold And Other Big Gainers From Tuesday
    Via Benzinga
    AVEO ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AVEO Oncology - AVEO
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Crude Oil Drops Over 2%; Akouos Shares Spike Higher
    Via Benzinga
    Nasdaq Rises Over 100 Points; Goldman Sachs Tops Q3 Views
    Via Benzinga
    Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Zovio (ZVO) Stock Soars 90% Ahead of Oct. 25 Dissolution Vote
    Via InvestorPlace
    Looking Into AVEO Pharmaceuticals's Recent Short Interest
    Via Benzinga
    Why Is Ra Medical (RMED) Stock Up 25% Today?
    Via InvestorPlace
    US Stocks Extend Monday's Gains; Dow Jumps Over 500 Points
    Via Benzinga
    What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
    Via InvestorPlace
    Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.